Bravada Intl Stock Price, News & Analysis
Company Description
Bravada Intl (OTC Link: BRAV) is a publicly traded internet retail company in the Consumer Cyclical sector. The company has a market capitalization of $187.5K.
BRAV stock has declined 100.0% over the past year. Shares last traded at $0.0000.
This page provides a comprehensive overview of BRAV stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Bravada Intl (BRAV) stock last traded at $0.0000. Over the past 12 months, the stock has lost 100.0%. At a market capitalization of $187.5K, BRAV is classified as a micro-cap stock with approximately 1.9B shares outstanding.
Latest News
Bravada Intl has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 5 with negative movement. Key topics include earnings. View all BRAV news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Bravada Intl (BRAV) currently stands at 9.6 thousand shares. With 1000.0 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Bravada Intl (BRAV) currently stands at 1000.0 days. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has increased 99899% over the past year, indicating improving liquidity conditions. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
BRAV Company Profile & Sector Positioning
Bravada Intl (BRAV) operates in the Internet Retail industry within the broader Consumer Cyclical sector and is listed on the OTC Link.
Investors comparing BRAV often look at related companies in the same sector, including Yuka Group Inc (YUKA), JIVA Tech (PLTXF), Medical Care Technologies Inc (MDCE), Kidpik Corp (PIKM), and Logicbio Therapeutics (LOGC). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate BRAV's relative position within its industry.